SDRC Investigator Natalie Torok Unveils New Insights on Liver Cancer Risk in Type 2 Diabetes Patients

A Stanford Medicine study led by Natalie Torok suggests revised screening guidelines, highlighting viscoelasticity as a key biophysical marker for liver cancer in diabetics, challenging traditional approaches to diagnosis.

Previous
Previous

Breakthrough Study led by SDRC Investigator Katrin Svensson Identifies Ozempic Rival For Weight Loss Without The Side Effects

Next
Next

SDRC Investigators Michael Snyder and Tracey McLaughlin Harness AI to Predict and Identify Type 2 Diabetes Subtypes Using Simple Glucose Monitors